tagged w/ GM
-
WA'S non-genetically modified (GM) grain sector could vanish within the next 10 years due to contamination from GM crops, some farmers and conservation groups fear.
Nic Dunlop, environmental science and policy co-ordinator for the Conservation Council of WA, says feral GM canola plants have been found on road verges in the state's Esperance district some 20 kilometres away from the nearest GM crop.
The discovery shows that the requirement for a five-metre gap between GM and non-GM crops under the state government's limited commercial-size trials is ineffective.
The main purpose of the trials is to assess whether segregation is possible.
Dr Dunlop said GM-free canola could be a thing of the past in WA by the next decade, given that eight per cent of roadside plants recently sampled by the Conservation Council in the Esperance region were GM, only one year into the trial.
``It doesn't matter what you're doing on the farm - the trucks are spreading it around the countryside,'' Dr Dunlop told AAP.
Canola seed is very fine, so it falls through holes in trucks.
This is evident by the abundance of GM canola ``fugitives'' in areas where road vibration is high such as grates and bumps, Dr Dunlop said.
Janet Cotter, senior scientist at Greenpeace's University of Exeter-based science unit, said she suspected WA's feral canola population would be entirely GM within a few years.
Dr Cotter warned that the ``tolerance'' level for GM contamination in non-GM canola - 0.9 per cent - would rise incrementally with each year the trials were held.
However, WA Agriculture and Food Minister Terry Redman says he's confident the level of gene-flow between canola crops will remain acceptable.
Mr Redman said a five-metre gap between crops to keep GM contamination under 0.9 per cent was the benchmark standard in Australia and was ``more than sufficient''.
``I'm talking 0.01 per cent - nothing near 0.9 per cent,'' Mr Redman told AAP.
He rejected assertions by anti-GM groups that grain customers in Japan wanted GM-free products, which attracted a premium price.
The Japanese benchmark tolerance level for GM contamination was much higher at five per cent, he added.
Mr Redman said the non-GM market in Japan was small and WA would continue to be able to supply those customers.
On a recent trip to Japan, only one out of half a dozen importers of WA grain had raised concerns about the GM trials, Mr Redman said.
``They are saying `we are happy with segregation arrangements and we're happy that we are able, if we choose to meet our consumer needs and import non-GM canola from WA'.
``It is simply a furphy to say that what we've done in WA ... is a barrier to trade in the Japanese market.''
Janette Liddlelow, a non-GM grain farmer in the WA Wheatbelt town of Williams, argued that the sector was more significant than Mr Redman claimed.
Ms Liddlelow also said the minister had failed to deliver on a handful of conditions to the trial, including a public register of GM growers, mandatory random audits of GM farms and GM-free marketing zones.
There was angst in Williams, where non-GM farmers wondered whether their neighbours were growing GM crops.
More at the linkWA'S non-genetically modified (GM) grain sector could vanish within the next 10... more
-
-
-
This short film from the STEPS Centre brings together an engaging cast of characters including a farmer, a scientist, a regulator and a seed policy analyst.
Each has a different view about how best to secure seeds for farmers growing maize -- Kenya's key staple crop - in drought-prone regions of the country.
The film shows the importance of informal seed systems, as well as formal ones, for food security in these areas. It shows how policy changes underway could have serious impacts on farmers struggling for sustainability in a changing climate.
More information: http://www.steps-centre.org/filmsThis short film from the STEPS Centre brings together an engaging cast of characters... more
-
-
Americans are in the market for more energy-efficient and cleaner-running cars. In his State of the Union address to Congress last month President Obama challenged the U.S. automotive industry produce more electric-powered alternatives.Americans are in the market for more energy-efficient and cleaner-running cars. In his... more
-
-
ptr23
-
added this
-
10 months ago
- |
-
US giant General Motors will invest $540 million to produce two low-emission motors in central Mexico, the company announced here Thursday, accompanied by President Felipe Calderon.
The latest project for GM in Mexico would create 500 direct and another 500 indirect jobs in its plant in Toluca, Calderon said.
GM has four plants in Mexico, and has invested some $5 billion here since 2006, Calderon said.
GM was left reeling by an industry slump when the global economic crisis hit. It received 49.5 billion dollars from the US Treasury and emerged from a bankruptcy restructuring in 2009.
It successfully returned to public trading last November by raising 23.1 billion dollars in an initial stock offering — the largest in history.
http://redwhitebluenews.com/?p=14524US giant General Motors will invest $540 million to produce two low-emission motors in... more
-
-
If you're in most parts of the United States, outside of the Midwest, you might wonder what the Ethanol brouhaha is all about. It's easy for some to dismiss the fuel as a diversion of resources, but there's more to it.
FlexFuel capable vehicles can use domestically produced E85 fuel, which has the potential to produce loads of horsepower and displace a significant amount of imported petroleum. While corn is the most prevalent Ethanol feedstock in America, this will change over time ...If you're in most parts of the United States, outside of the Midwest, you might... more
-
-
In a one-line film remark as surprisingly concise as it is political and timely, a American blue collar woman explains to her son why they've permanently moved to China.
"There's nothing left for us in Detroit," she tells her son (played by Jaden Smith, the main character). The film is not Stephen Gaghan's 2005 film Syriana, it's Harald Zwart's 2010 remake of The Karate Kid.
Robert Kuttner (more to come)In a one-line film remark as surprisingly concise as it is political and timely, a... more
-
-
General Motors, the same automaker that's been winning awards with the gasoline-optional Chevrolet Volt, is clearly going after the fossil-fuel crowd with a 550-horsepower version of its Camaro performance coupe unveiled at the Chicago Auto Show Wednesday.General Motors, the same automaker that's been winning awards with the... more
-
-
It looks, sounds and, according to its creators, tastes like a normal pig.
But this is no ordinary farmyard animal. The specially-bred Yorkshire pig is the first of a new generation of ‘Frankenswine’ – genetically modified hogs designed to be cheaper and greener.
The creators of the GM superpig, nicknamed the Enviropig, say its manure contains less phosphorus than normal slurry and poses less risk to rivers, streams and lakes.
But critics of GM food said the animals are ‘anything but environmentally friendly’ – and could lead to more intensive pig farms.
Researchers have been working on the Enviropig for more than a decade.
They believe it will be the first GM animal to be allowed into the food chain and could one day provide sausages, bacon and pork for the world.
Like all creatures, pigs need phosphorus in their diet to help form strong bones, teeth and cell walls.
They are fed primarily on cereals which contains a type of phosphorus that they cannot digest. Most farmers have to feed pigs an enzyme called phytase to make plant phosphorus digestible.
But phytase supplements are not very good at breaking down phosphorus, so a large amount is flushed out of their bodies in waste.
The phosphorous-rich manure can make its way into the water supply where it triggers algal blooms, which choke aquatic life and create ‘dead zones’ for fish.
Unlike normal pigs, Enviropigs have been designed to produce their own phytase.
Researchers took a gene responsible for the creation of phytase from an E.coli bacteria and added it to the genetical make-up of a Yorkshire pig.
To make sure the bacterium gene would work in the animal, they combined it with a gene taken from a mouse before inserting it into the Enviropig’s DNA.
In tests, the Enviropig was able to absorb more phosphorous from its feed. Its waste contained less of the potentially toxic substance.
Its meat also appears to be identical to cuts from a traditional Yorkshire pig.
One of the pig’s creators, Professor Rich Moccia, of the University of Guelph, in Ontario, Canada, told the BBC: ‘They are pretty friendly and pretty gregarious.
'These pigs are almost identical to a normal Yorkshire pig. They look normal, they grow normally and they behave normally.’
Earlier this year the Canadian government approved the animal for production and breeding in laboratories. But it is still not allowed in the food chain – and is years away from being approved.
Vicky Hird, of Friends of the Earth, said the name Enviropig ‘was a huge irony’.
She added: ‘Pigs reared in these intensive units can never be sustainable because they require so much soya which is grown by clearing forests which leads to more greenhouse gases being released.
‘And when it comes to GM food, consumers are voting with their feet. They won’t accept it.’
Read more: http://www.dailymail.co.uk/sciencetech/article-1344172/Frankenswine-Pigs-genetically-modified-smell.html#ixzz1AFhIp46dIt looks, sounds and, according to its creators, tastes like a normal pig.
But this... more
-
-
"I'm not saying it was a tough crowd but I cleared that room like the Marines cleared Fallujah." Stand-up comedian Chris Martin performs his last set before retiring due to Alzheimer's at Wabi-Sabi in Petersburg, VA. Jason Klingman is MC.
http://www.chrismartincomedy.com"I'm not saying it was a tough crowd but I cleared that room like the... more
-
-
"Elton John performed for for one million dollars at Rush Limbaugh's wedding. Apparently he also played the piano." Stand-up comedian Chris Martin delivers his final set before retiring due to Alzheimer's June June 23, 2010 at Refried Comedy @ Aztek Grill. Odyssey Michaels is the MC."Elton John performed for for one million dollars at Rush Limbaugh's... more
-
-
"The Texas Board of Education wanted to rename the slave trade "the Atlantic Triangular trade. It turns out the ovens at Auschwitz were actually tanning beds." Stand-up comedian Chris Martin tackles some touchy topics at Refried Comedy @ Aztek Grill. Odyssey Michael is the host."The Texas Board of Education wanted to rename the slave trade "the Atlantic... more
-
-
Wall Street recibió un importante impulso en las primeras operaciones por el inicio de las cotizaciones de GM, cuya oferta pública estableció un nuevo récord de colocación. A esto se sumaron datos económicos positivos y buenas noticias provenientes de Europa.Wall Street recibió un importante impulso en las primeras operaciones por el... more
-
-
The added shares vaulted GM past Agricultural Bank of China’s (601288.SS) $22.1 billion IPO in July and underscored the strong demand for the taxpayer-rescued automaker’s stock.
GM said on Friday that underwriters led by Morgan Stanley (MS.N), JPMorgan Chase & Co (JPM.N), Bank of America Merrill Lynch (BAC.N) and Citigroup Inc (C.N), exercised their full option on an additional 71.7 million common shares worth $2.37 billion.
They also exercised an option to purchase 13 million preferred shares for $650 million.
http://www.theblogismine.com/2010/11/27/gms-initial-public-offering-became-worlds-biggest/The added shares vaulted GM past Agricultural Bank of China’s (601288.SS) $22.1... more
-
-
Rush Limbaugh just wants his internal combustion engine back. Just like the founding fathers envisioned when they invented cars at the Constitutional Convention. Or something like that.
In any case, Limbaugh is unhappy with the liberal media at Motor Trend because they named the Chevrolet Volt their 2011 Car of the Year.
Nov. 22, Motor Trend, quoting Limbaugh: “Folks, of all the cars, no offense, General Motors, please, but of all the cars in the world, the Chevrolet Volt is the Car of the Year? Motor Trend magazine, that’s the end of them. How in the world do they have any credibility? Not one has been sold. The Volt is the Car of the Year.”
Motor Trend’s Todd Lassa quickly dismisses the specious “not one has been sold” argument by noting the Volt hasn’t yet gone on sale. Their decision to name GM’s plug-in electric as Car of the Year was based on test drives and other pre-sale reviews of the Volt.
There’s perhaps a legitimate criticism here about all Car of the Year awards processes. These awards are given to new or completely overhauled models. Until we see how a car performs in real world conditions over an extended period of time, the pronouncements of automotive journalists are basically educated guesses.
However, you don’t hear Limbaugh or anyone else raising a stink about past forgettable Motor Trend Cars of the Year. No one ever takes the magazine to task for fawning over the completely style-less 1995 Chrysler Cirrus or equally bland 1997 Chevy Malibu.
Limbaugh’s beef with the Volt isn’t a question of automotive aesthetics or engineering. He just doesn’t like the Volt because it’s one of them librul eel-eck-trick cars that Muslim-Socialist Obama forced on the real ‘Mericans in Detroit.
That an interesting theory. Interesting, in so far as it’s completely made up. As Lassa explains, the Volt was unveiled as a concept car in January 2007 and championed by GM’s in-house environmental skeptic Bob Lutz. At which point, Lassa suggests Limbaugh (soberly) drive one for himself.
Nov. 22, Motor Trend: All the shouting from you or from electric car purists on the left can’t distort the fact that the Chevy Volt is, indeed, a technological breakthrough. And it’s more. It’s a technological breakthrough that many American families can use for gas-free daily commutes and well-planned vacation drives. It’s expensive for a Chevy, but many of those families will find the gasoline saved worth it. If you can stop shilling for your favorite political party long enough to go for a drive, you might really enjoy the Chevy Volt. I’m sure GM would be happy to lend you one for the weekend. Just remember: driving and Oxycontin don’t mix.
Some might call that last line a cheap shot, but it’s hard to consider Limbaugh without factoring in his history of drug abuse. Back in the 1990s, even Limbaugh’s most hardened critics would concede the man had wit and style. Today, he seems more like another angry man looking to shout at clouds than anything else.
From his "phony soldiers" comments to mocking Michael J. Fox’s Parkinson’s Disease to suggesting that Donavan McNabb – 32nd all-time quarterback rating, ahead of Troy Aikman and Bart Starr – was over-rated, Limbaugh’s rantings betray more than just controversial political opinions. They suggest a man divorced from reality.
There’s some evidence that long-term Oxycontin addiction can permanently diminish brain function:
Livestrong.com: Oxycontin abuse can result in problems in the brain and heart. For example, Oxycontin abuse can result in a build-up of cerebrospinal fluid in the brain, which puts pressure on the tissue. The increase pressure in the skull can cause changes in mental function, such as confusion.
It seems reasonable to ask, after these increasingly regular controversies, if Limbaugh is still playing with a full deck.
After all, he’d be the first to raise the issue if it was his political enemy, with a five year-plus prescription opiate addiction, making repeated baseless assertions about almost every subject under the sun.Rush Limbaugh just wants his internal combustion engine back. Just like the founding... more
-
-
Media reports last night and this morning (including all three network newscasts) hail General Motors' return to the stock market, and note what ABC World News called President Obama's "victory lap" over the company's turnaround. Coverage of the President's brief remarks was positive on both TV and print
http://www.freep.com/article/20101118/BUSINESS0101/101118068/1318/Text-of-Obamas-speech-on-GMMedia reports last night and this morning (including all three network newscasts) hail... more
-
-
General Electric will convert half its 30,000 worldwide fleet of vehicles to electrics, including purchasing 12,000 cars from GM beginning with the 2011 Chevrolet Volt, the company said today.
In all, the Fairfield, Conn.-based company, which makes charging stations, will purchase 25,000 plug-in electric cars by 2015, adding electric vehicles from other automakers as they expand their lineup of battery-powered cars.
The first Volts start rolling off the assembly line at the Detroit-Hamtramck plant this month. In its first year, GM plans to sell only 10,000 Volts, eventually expanding production to 45,000 in 2012. A GM spokesman said this morning that it won't ramp up production further to fill GE's order. GE will receive its first 1,000 Volts in mid to late 2011 with 2,000 to 3,000 more arriving each following year until 2015, GM said. The automaker wouldn't release details about how much GE is paying for the bulk fleet order or the shipping costs.
GM CEO Dan Akerson said in a statement issued by the automaker that GE's commitment reflects its confidence in electric vehicles.
"It is also a vote of confidence in the Chevrolet Volt, which we will begin delivering to retail customers by the end of this year," Akerson added.
"We are pleased that the Volt will play a major role in this program, which will spur innovation and benefit our companies, our customers, and society as a whole."
The Volt is an extended range hybrid that gets between 25 and 50 miles on battery power alone, before a gasoline engine kicks in, extending its range another 310 miles.
"GE's purchase will drive sales to help GM offset the vast investment it made in pioneering technologies. Automakers are unlikely to make money on new technologies out of the starting gate, but a big purchase like this helps accelerate their return on investment," said Edmunds.com senior analyst Michelle Krebs.General Electric will convert half its 30,000 worldwide fleet of vehicles to... more
-
-
An interesting report prepared by Russia’s Ministry of Industry and Trade for President Medvedev for his visit to China this week states that United States President Barack Obama [photo top left showing him bowing to Chinese Communist leader Hu Jintao] has “agreed in principal” to sell the American governments 61% ownership of US auto giant General Motors (GM) to China’s SAIC Motor Corporation, who has been GM’s partner and instrumental in their success in that Communist Nation and who already owns half of GM’s Indian division.
http://www.pakalertpress.com/2010/09/29/obama-to-sell-us-auto-giant-gm-to-china-as-pentagon-looks-to-coup/An interesting report prepared by Russia’s Ministry of Industry and Trade for... more
-
-
Seed farmers throughout the United States are complaining that biotech seeds (which are genetically altered seeds) are becoming much too expensive, resistant to weed killer, and can contaminate conventional seed crops. However, they still continue to use the seeds. But with anticompetitive practices being investigated on biotech seed companies, seed farmers may change their minds.
"The technology has really been hyped up a lot," said Doug Gurian-Sherman, author of a 2009 study for the Union of Concerned Scientists, which concluded that yield increases have come mainly from conventional plant breeding. "Even on a shoestring, conventional breeding outperforms genetic engineering.
Genetically altered seed is used by a majority of U.S. farmers because weeds at one time were much easier to kill with herbicides such as Roundup. Also, these biotech crops, like corn, contained genes that allowed them to "manufacture" their own insecticide meaning farmers did not have to pay money and spend time killing insects with store-bought insecticides. In addition, biotech seed companies like Monsanto have created a monopoly in the seed business, buying smaller seed businesses and selling nothing but their genetically engineered seed. Traditional seed has even become hard to find because most "crop improvements" produced by conventional plant breeding are only sold together with biotech traits.
But with rising costs and recent resistance to herbicides, biotech seed has become less favorable and farmers are taking notice. For instance, last year, the price of biotech soybean seeds rose 24 percent while corn seed rose 32 percent. The U.S. Justice Department is investigating the anticompetitive practices of Monsanto, and Monsanto is countering by saying it plans on offering more seed options at lower prices next year.
"There just isn't competition out there," said Craig Griffieon, a farmer in Ankeny, Iowa.
Biotech crops have grown resistant to herbicides mainly in cotton fields in the Southern United States where giant ragweed and horsetails are affecting thousands of acres. But the problem is spreading toward the midwest now as well.
As far as genetic contamination of traditional crops that are grown near biotech crops goes, farmers have testified that biotech crops have lowered the value of their conventional crops.
"If you've got your conventional seed right next to your neighbor's [biotech] seeds, the pollen flies," said John Schmitt, a farmer from Quincy, Illinois who had to sell a third of his conventional corn for much lower prices due to genetic contamination. "It's nature."
A majority of farmers still use biotech seed also because they believe that biotech seed yields more crop at harvest, but even Monsanto doesn't argue that most of the increase in crop yields is due to traditional plant breeding. Conventional seeds produce just as well as biotech seeds, but as noted before, conventional seed is becoming harder to find.
While biotech seed is used more so than conventional, farmers are slowly getting the picture by realizing that there aren't many benefits to genetically altered seed as opposed to conventional seed. According to the latest statistics, the amount of farms using biotech seeds only rose one percent last year, from 85 percent to 86 percent. This is the smallest increase since 2001. In Illinois specifically, the percentage of acres using biotech corn seed decreased from 84 percent to 82 percent, where soybeans reduced as well from 90 percent to 89 percent.Seed farmers throughout the United States are complaining that biotech seeds (which... more
-
-
Rockville, MD Even though the FDA held hearings about how AquAdvantage Salmon should be labeled the day after hearings about if it should be approved this week, it said it has not decided yet about the genetically engineered fish.
Unfortunately, its invited speakers didn’t get the memo.
Presenting to the Veterinary Medicine Advisory Committee (VMAC) on Monday, Yonathan Zohar, from the Center of Marine Biotechnology at the University of Maryland, extolled the “promise” of aquaculture and bashed Greenpeace and other groups who are against growing “fish in cages.”
And, Alison Van Eenennaam, with the Department of Animal Science at University of California-Davis, declared during labeling hearings on Tuesday, that GE salmon “poses no additional risk,” criticized the New York Times’ AquAdvantage Salmon coverage and laughed at peanut allergy labels. She also served on the veterinary committee advising the FDA, the previous day.
The AquAdvantage Salmon was created by inserting the coding sequence from a chinook salmon growth hormone gene, under control of an ocean pout gene, into wild Atlantic salmon. The resulting fish grows twice as fast as wild Atlantic salmon, reaching its full size in 18 months instead of three years.
Though the fish, all female, are 95 to 99 percent sterile, Boston-based Aqua Bounty Technologies’ (ABT), its developer, says eggs will be grown on Prince Edward Island in Canada and adults in Panama because the respective marine environments discourage survival of escapees.
The FDA has approved GE crops, genetically modified bovine growth hormone (BGH) used in milk and, last year, a goat with human genes to create a blood clotting drug. But the AquAdvantage Salmon is the first GE animal whose flesh will actually be eaten.
Because the AquAdvantage Salmon is affected by a “transformation event” and the injected DNA “imparts traits” to the animal, the salmon’s application is actually being treated as a “new animal drug approval,” hence a vet committee.
Some say the public health orientation of the new top two at FDA, Commissioner Margaret Hamburg and Deputy Commissioner Joshua Sharfstein (who spoke Monday and Tuesday) will spell a harsher climate for genetically engineered foods. The public is also becoming less GE friendly and rejected BGH in milk in 2006, 13 years after it received FDA approval.
But FDA staffers who spoke at the hearings read right out of Aqua Bounty Technologies’ playbook, creating distinctions between “risk,” “hazard” and “harm” — ice is only a risk if you slip on it they pointed out — that made the fish appear safer. http://bit.ly/bEJZlr
FDA staffers also said the AquAdvantage Salmon had minimal impact on the “human environment” until the advisory committee asked as opposed to what other kind of environment whereupon the term was dropped.
FDA’s Eric Silberhorn itemized ABT’s redundant safety systems to prevent the escape of GE salmon — screens, floor drains, chemical containment, chlorine, nets — as written in the sponsor’s Environmental Assessment, prepared for the FDA, bringing to mind BP.
Why does the government present industry data on behalf of industry, some in the audience asked, and why is industry called the “sponsor” instead of “applicant”?
AquAdvantage Salmon were also said to be less “fit” if they escape though no one quoted the part of ABT’s Environmental Assessment report that says the salmon eat five times as much as wild salmon and have less fear of predators. (see: Jurassic Park)
The risk of bootleg AquAdvantage Salmon surfacing in unregulated Asian operations, even returning as imports like a “transgenic shrimp” Silberhorn says is reported in US food, would be handled with the labeling, control and inspection given any US drug, said staffers. Of course other nations, like Canada and Panama are “sovereign” and not bound by our laws, added FDA’s Larisa Rudenko.
Frankenfish Fears
While the FDA did not use the loaded terms drift and mutate (or Frankenfish) it did request a “durability” report from ABT to make sure nothing genetically untoward happens.
And its Center for Veterinary Medicine briefing report finds an unexpected and unwanted genetic “rearrangement” with the AquAdvantage Salmon which relocates the inserted genetic material from “the far upstream promoter regions” to a “downstream location relative to the growth hormone coding region.” Oops. The loss of part of a “35 base repeat region” and possible duplication of another effect were also reported. http://bit.ly/clF7D0
Asked by the committee if the genetic unknowns could create unanticipated events, Jeff Jones, a veterinarian presenter at the hearings, said the changes were “not subject to the hormone feedback system” in the fish and that the relocated genetic construct currently abuts “something that can’t be read.”
Elsewhere in its report, the FDA finds low glucose levels and high incidences of jaw erosion, focal inflammation and insulin-like growth factor 1 (IGF-1) in the AquAdvantage Salmon but concludes, giving no evidence, they are not caused by the genetic engineering.
While the FDA report says ABT’s excessive culling of “abnormal” salmon may have “skewed” safety studies, it does not question ABT’s proposed method of disposing of salmon affected by the 3Ms, mutations, morbidity and mortality.
“As dead fish are deposited, they will be covered with caustic lime, followed by another layer of dead fish and caustic lime, etc., until the burial pit is ~0.5 m deep, at which point it will sealed with plastic and covered with soil,” says ABT’s Environmental Assessment. “In the event that disposal capacity at the site is inadequate to handle the immediate or aggregate waste volume, alternative means of disposal will be sought.”
Antibiotics, veterinary drugs and coded antibiotic resistance were barely mentioned at the hearings (though Zohar predicted egg farm like densities of up “80 to 100 per cubic meter for the GE salmon) — nor was the practice of harvesting wild fish to feed farmed fish (though one invited speaker actually promoted the practice.)
In fact there was only one meltdown in the FDA’s otherwise confident presentation and it concerned ABT’s allergy study whose, “technical flaws… so limit its interpretation that we can not rely on its results,” says the FDA report.
When FDA food scientists Kathleen Jones and Kevin Greenlees presented the allergy research, which sought to establish safety levels with no number that would be unsafe, the advisory committee pounced.
“It’s as if you selected an allergen in goat meat and one in sheep meat and compare the two and found a difference,” said Louisiana State University’s David F. Senior, who chaired the committee. “Who cares?”
“These studies are a bust,” said another committee member, asking why they were not conducted again.
“I am not a statistician and she is not here today,” retreated Jones, adding that the studies were absolutely “above board,” though no one had suggested they weren’t.
“You’ve reached the limit of my statistical” knowledge said Larisa Rudenko.
And when James D. McKean with the Department of Veterinary Diagnostic and Production Animal Medicine at Iowa State University asked why a category of salmon suddenly was dropped from a table as a lone, extra salmon seemed to appear out of nowhere, FDA’s Greenlees said, “It’s my fault” and “I apologize.”
Many hope an apology for considering an approval of the AquAdvantage Salmon itself is forthcoming.
http://blogs.alternet.org/wp-content/avatars/default.jpgRockville, MD Even though the FDA held hearings about how AquAdvantage Salmon should... more
-
